Vault-13

Ponoi II Management, LLC

San Francisco, CA · CIK 1746488 · 13F filing filed 2022-08-12

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$36.8m reported value -18.3% vs Q1 2022
4positions
100.0%in top 10
0 new 0 added 0 reduced 0 sold out vs Q1 2022

Holdings, Q2 2022

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 NGM BIOPHARMACEUTICALS INC COM NGM NGM 1,298,908 $16.7m45.25% 45.25% UnchangedShares held: Q3 2021 1.3m, Q4 2021 1.3m, Q1 2022 1.3m, Q2 2022 1.3m
2 REVOLUTION MEDICINES INC COM RVMD RVMD 685,011 $13.4m36.28% 36.28% UnchangedShares held: Q3 2021 685.0k, Q4 2021 685.0k, Q1 2022 685.0k, Q2 2022 685.0k
3 NURIX THERAPEUTICS INC COM NRIX NRIX 327,123 $4.1m11.26% 11.26% UnchangedShares held: Q3 2021 561.6k, Q4 2021 327.1k, Q1 2022 327.1k, Q2 2022 327.1k
4 RAPT THERAPEUTICS INC COM COM 145,401 $2.7m7.21% 7.21% UnchangedShares held: Q3 2021 145.4k, Q4 2021 145.4k, Q1 2022 145.4k, Q2 2022 145.4k